{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:32:20Z","timestamp":1792668740730,"version":"4.5.0"},"reference-count":148,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1053\/j.semdp.2019.12.004","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T19:43:10Z","timestamp":1576611790000},"page":"32-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis"],"prefix":"10.1053","volume":"37","author":[{"given":"Ivonne A.","family":"Montes-Mojarro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wook Youn","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falko","family":"Fend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7156-5365","authenticated-orcid":false,"given":"Leticia","family":"Quintanilla-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2019.12.004_bib0001","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/annonc\/mdp064","article-title":"Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008","volume":"20","author":"Cohen","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0002","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from Burkitt's lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"10.1053\/j.semdp.2019.12.004_bib0003","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc.2016.92","article-title":"Epstein-Barr virus: more than 50 years old and still providing surprises","volume":"16","author":"Young","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.semdp.2019.12.004_bib0004","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2019.12.004_bib0005","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","article-title":"The immunology of Epstein-Barr virus-induced disease","volume":"33","author":"Taylor","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"10.1053\/j.semdp.2019.12.004_bib0006","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1182\/blood.V85.3.744.bloodjournal853744","article-title":"Morphology, immunophenotype, and distribution of latently and\/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus","volume":"85","author":"Anagnostopoulos","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.004_bib0007","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/modpathol.3800369","article-title":"Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils","volume":"18","author":"Hudnall","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0008","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s12026-014-8496-1","article-title":"The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease","volume":"58","author":"Hatton","year":"2014","journal-title":"Immunol Res"},{"key":"10.1053\/j.semdp.2019.12.004_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens7010028","article-title":"EBV-Positive lymphoproliferations of B- T- and NK-Cell derivation in non-immunocompromised hosts","volume":"7","author":"Dojcinov","year":"2018","journal-title":"Pathogens"},{"key":"10.1053\/j.semdp.2019.12.004_bib0010","doi-asserted-by":"crossref","first-page":"11139","DOI":"10.1128\/JVI.76.21.11139-11142.2002","article-title":"Evidence for early infection of nonneoplastic natural killer cells by Epstein-Barr virus","volume":"76","author":"Trempat","year":"2002","journal-title":"J Virol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0011","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1158\/0008-5472.CAN-03-1562","article-title":"Epstein-Barr virus infection of human natural killer cell lines and peripheral blood natural killer cells","volume":"64","author":"Isobe","year":"2004","journal-title":"Cancer Res."},{"key":"10.1053\/j.semdp.2019.12.004_bib0012","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"355","article-title":"EBV-positive T-cell and NK-cell lymphoproliferative diseases of childhood","author":"Quintanilla-Martinez","year":"2017"},{"issue":"Suppl 2","key":"10.1053\/j.semdp.2019.12.004_bib0013","first-page":"692","article-title":"[EBV-positive T\/NK lymphoproliferative disease in childhood]","volume":"70","author":"Kimura","year":"2012","journal-title":"Nihon Rinsho"},{"key":"10.1053\/j.semdp.2019.12.004_bib0014","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"368","article-title":"Extranodal NK\/T-cell lymphoma, nasal type","author":"Chan","year":"2017"},{"key":"10.1053\/j.semdp.2019.12.004_bib0015","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"353","article-title":"Aggressive NK-cell leukaemia","author":"Chan","year":"2017"},{"key":"10.1053\/j.semdp.2019.12.004_bib0016","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1017\/S0022215100118407","article-title":"Photographs of a case of rapid destruction of the nose and face. 1897","volume":"105","author":"McBride","year":"1991","journal-title":"J Laryngol Otol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0017","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the international peripheral T-Cell lymphoma project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.004_bib0018","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1046\/j.1365-2141.1997.1462962.x","article-title":"CD56+ NK lymphomas: clinicopathological features and prognosis","volume":"97","author":"Kwong","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0019","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.1998.16.1.70","article-title":"Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients","volume":"16","author":"Cheung","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0020","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1309\/2F39NX1AL3L54WU8","article-title":"NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype","volume":"127","author":"Hasserjian","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0021","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2141.2010.08461.x","article-title":"Central palatal perforation in nasal natural killer cell lymphoma","volume":"152","author":"Kwong","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0022","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13045-017-0452-9","article-title":"The diagnosis and management of NK\/T-cell lymphomas","volume":"10","author":"Tse","year":"2017","journal-title":"J Hematol Oncol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0023","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/annonc\/mdp418","article-title":"Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type","volume":"21","author":"Suzuki","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0024","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0b013e31826731b5","article-title":"Extranodal NK\/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center","volume":"37","author":"Li","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0025","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1046\/j.1365-2559.2002.13775.x","article-title":"Primary natural killer cell lymphoma of skeletal muscle","volume":"41","author":"Chim","year":"2002","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2019.12.004_bib0026","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/10245330400026162","article-title":"NK-cell neoplasms in Japan","volume":"10","author":"Oshimi","year":"2005","journal-title":"Hematology"},{"key":"10.1053\/j.semdp.2019.12.004_bib0027","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00277-008-0562-0","article-title":"Non-nasal natural killer cell lymphoma: not non-nasal after all","volume":"88","author":"Tse","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0028","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/1097-0142(19860701)58:1<67::AID-CNCR2820580113>3.0.CO;2-F","article-title":"Nasal T-cell lymphoma associated with hemophagocytic syndrome","volume":"58","author":"Ng","year":"1986","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2019.12.004_bib0029","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/00000478-199911000-00006","article-title":"Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital","volume":"23","author":"Cuadra-Garcia","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0030","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the international peripheral T-Cell lymphoma project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.004_bib0031","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1182\/blood-2008-05-160176","article-title":"Clinical features and treatment outcome of nasal-type NK\/T-cell lymphoma of Waldeyer ring","volume":"112","author":"Li","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.004_bib0032","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1470-2045(15)00533-1","article-title":"A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis","volume":"17","author":"Kim","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0033","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","article-title":"Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0034","first-page":"77","article-title":"Natural killer cell neoplasms","volume":"3","author":"Chan","year":"1998","journal-title":"Anatomic Path (Chicago, Ill.: annual)."},{"key":"10.1053\/j.semdp.2019.12.004_bib0035","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1182\/blood.V95.11.3628","article-title":"Expression of CD94\/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas","volume":"95","author":"Haedicke","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.004_bib0036","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood-2003-01-0295","article-title":"CD94 transcripts imply a better prognosis in nasal-type extranodal NK\/T-cell lymphoma","volume":"102","author":"Lin","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.004_bib0037","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0046-8177(99)90299-X","article-title":"Peripheral t and putative natural killer cell lymphomas commonly coexpress CD95 and CD95 ligand","volume":"30","author":"Ng","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0038","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1186\/1471-2407-14-890","article-title":"CD30 expression is a novel prognostic indicator in extranodal natural killer\/T-cell lymphoma, nasal type","volume":"14","author":"Li","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1053\/j.semdp.2019.12.004_bib0039","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3109\/10428194.2014.974048","article-title":"Prognostic implications of CD30 expression in extranodal natural killer\/T-cell lymphoma according to treatment modalities","volume":"56","author":"Kim","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2019.12.004_bib0040","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/106689690401200410","article-title":"Nasal NK\/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities","volume":"12","author":"Kuo","year":"2004","journal-title":"Int J Surg Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0041","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.humpath.2014.11.008","article-title":"Extranodal natural killer\/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors","volume":"46","author":"Jhuang","year":"2015","journal-title":"Hum. Pathol."},{"key":"10.1053\/j.semdp.2019.12.004_bib0042","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1182\/blood-2003-04-1286","article-title":"Aberrant BCL10 nuclear expression in nasal NK\/T-cell lymphoma","volume":"102","author":"Shen","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.004_bib0043","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1182\/blood.V89.12.4501","article-title":"Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm","volume":"89","author":"Chan","year":"1997","journal-title":"Blood"},{"issue":"Suppl 2","key":"10.1053\/j.semdp.2019.12.004_bib0044","article-title":"Epstein-Barr virus in T and natural killer (NK) cell non-Hodgkin\u2019s lymphomas","volume":"10","author":"Kanavaros","year":"1996","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2019.12.004_bib0045","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1349-7006.2003.tb01436.x","article-title":"Analysis of p53, K-ras, c-kit, and beta-catenin gene mutations in sinonasal NK\/T cell lymphoma in northeast district of China","volume":"94","author":"Hoshida","year":"2003","journal-title":"Cancer Sci"},{"key":"10.1053\/j.semdp.2019.12.004_bib0046","doi-asserted-by":"crossref","first-page":"17764","DOI":"10.18632\/oncotarget.3776","article-title":"Genetic alterations of JAK\/STAT cascade and histone modification in extranodal NK\/T-cell lymphoma nasal type","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"10.1053\/j.semdp.2019.12.004_bib0047","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/ncomms7025","article-title":"Activating mutations of STAT5B and STAT3 in lymphomas derived from gammadelta-T or NK cells","volume":"6","author":"Kucuk","year":"2015","journal-title":"Nat Commun"},{"key":"10.1053\/j.semdp.2019.12.004_bib0048","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ng.3358","article-title":"Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma","volume":"47","author":"Jiang","year":"2015","journal-title":"Nat Genet"},{"key":"10.1053\/j.semdp.2019.12.004_bib0049","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/gcc.22348","article-title":"Frequent BCOR aberrations in extranodal NK\/T-Cell lymphoma, nasal type","volume":"55","author":"Dobashi","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.semdp.2019.12.004_bib0050","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nm.4456","article-title":"Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK\/T cell lymphoma","volume":"24","author":"Wen","year":"2018","journal-title":"Nat Med"},{"key":"10.1053\/j.semdp.2019.12.004_bib0051","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0002-9440(10)63061-1","article-title":"p53 mutations in nasal natural killer\/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease","volume":"159","author":"Quintanilla-Martinez","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0146","article-title":"Mutational profile and EBV strains of extranodal NK\/T-cell lymphoma, nasal type in Latin American","author":"Montes-Mojarro","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0052","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2009.3","article-title":"Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies","volume":"23","author":"Iqbal","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2019.12.004_bib0053","doi-asserted-by":"crossref","first-page":"20119","DOI":"10.1073\/pnas.1115128108","article-title":"PRDM1 is a tumor suppressor gene in natural killer cell malignancies","volume":"108","author":"Kucuk","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semdp.2019.12.004_bib0054","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1080\/1042819031000123410","article-title":"Deletion mapping of the long arm of chromosome 6 in peripheral T and NK cell lymphomas","volume":"44","author":"Yoon","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2019.12.004_bib0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/gcc.20245","article-title":"Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma\/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal NK\/T-cell lymphoma, nasal type","volume":"44","author":"Nakashima","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.semdp.2019.12.004_bib0056","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/his.13463","article-title":"Aggressive natural killer (NK)-cell leukaemia and extranodal NK\/T-cell lymphoma are two distinct diseases that differ in their clinical presentation and cytogenetic findings","volume":"72","author":"Yang","year":"2018","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2019.12.004_bib0057","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1182\/blood-2010-11-319913","article-title":"A sheep in wolf\u2019s clothing","volume":"117","author":"Porcu","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.004_bib0058","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1055\/s-2001-15713","article-title":"[Angiocentric T\/NK cell lymphoma: a special clinical-pathological entity of lethal midline granuloma. A case report]","volume":"80","author":"Koch","year":"2001","journal-title":"Laryngorhinootologie"},{"key":"10.1053\/j.semdp.2019.12.004_bib0059","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/PPO.0b013e31826c5e19","article-title":"Lymphomatoid granulomatosis","volume":"18","author":"Roschewski","year":"2012","journal-title":"Cancer J (Sudbury, Mass.)"},{"key":"10.1053\/j.semdp.2019.12.004_bib0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.semdp.2016.11.009","article-title":"Cutaneous lymphomas with a panniculitic presentation","volume":"34","author":"Willemze","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0061","article-title":"Primary intestinal extranodal natural killer\/T-cell lymphoma, nasal type: a comprehensive clinicopathological analysis of 55 cases","volume":"11","author":"Yu","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1053\/j.semdp.2019.12.004_bib0062","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-8-95","article-title":"Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis","volume":"8","author":"Lima","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1053\/j.semdp.2019.12.004_bib0063","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/ajh.2830380412","article-title":"Hemophagocytic syndrome associated with aggressive natural killer cell leukemia","volume":"38","author":"Okuda","year":"1991","journal-title":"Am J Hematol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0064","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/10428190009054881","article-title":"Epstein-Barr virus-infected natural killer cell leukemia","volume":"40","author":"Akashi","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2019.12.004_bib0065","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00277-007-0278-6","article-title":"Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome","volume":"86","author":"Han","year":"2007","journal-title":"Ann Hematol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0066","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/cncr.23316","article-title":"Natural killer cell neoplasms","volume":"112","author":"Liang","year":"2008","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2019.12.004_bib0067","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/pbc.21358","article-title":"Aggressive natural killer cell leukemia presenting with hemophagocytic lymphohistiocytosis","volume":"50","author":"Petterson","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1053\/j.semdp.2019.12.004_bib0068","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1586\/ehm.10.51","article-title":"Diagnosis and management of natural killer-cell malignancies","volume":"3","author":"Ishida","year":"2010","journal-title":"Expert Rev Hematol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0069","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1080\/10428190412331283233","article-title":"Marked elevation of soluble fas ligand and cytokine secretion after splenectomy in aggressive natural killer cell leukemia\/lymphoma","volume":"45","author":"Kaizu","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2019.12.004_bib0070","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/1097-0142(19881101)62:9<1918::AID-CNCR2820620909>3.0.CO;2-8","article-title":"Fulminant clonal expansion of large granular lymphocytes. Characterization of their morphology, phenotype, genotype, and function","volume":"62","author":"Ohno","year":"1988","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2019.12.004_bib0071","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1182\/blood.V72.5.1701.1701","article-title":"Leukemia of non-T lineage natural killer cells","volume":"72","author":"Sheridan","year":"1988","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.004_bib0072","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41408-017-0021-z","article-title":"Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes","volume":"7","author":"Tang","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1053\/j.semdp.2019.12.004_bib0073","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3960\/jslrt.51.21","article-title":"The diagnosis and management of extranodal NK\/T-cell lymphoma, nasal-type and aggressive NK-cell leukemia","volume":"51","author":"Kwong","year":"2011","journal-title":"J Clin Exp Hematop"},{"key":"10.1053\/j.semdp.2019.12.004_bib0074","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/sj.leu.2403262","article-title":"Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells","volume":"18","author":"Suzuki","year":"2004","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2019.12.004_bib0075","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.leukres.2006.10.020","article-title":"Chemokine system and tissue infiltration in aggressive NK-cell leukemia","volume":"31","author":"Makishima","year":"2007","journal-title":"Leuk. Res."},{"key":"10.1053\/j.semdp.2019.12.004_bib0076","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/PAS.0000000000000735","article-title":"EBV-negative aggressive NK-cell leukemia\/lymphoma: clinical, pathologic, and genetic features","volume":"41","author":"Nicolae","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0077","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0002-9440(10)65454-5","article-title":"Comparative genomic hybridization analysis of natural killer cell lymphoma\/leukemia. Recognition of consistent patterns of genetic alterations","volume":"155","author":"Siu","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0078","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10428199909050949","article-title":"Cytogenetic abnormalities in natural killer cell lymphoma\/leukaemia\u2013is there a consistent pattern?","volume":"34","author":"Wong","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2019.12.004_bib0079","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/(SICI)1098-2264(200001)27:1<52::AID-GCC7>3.0.CO;2-X","article-title":"A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization","volume":"27","author":"Zhang","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.semdp.2019.12.004_bib0080","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41467-018-03987-2","article-title":"Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight jak-stat signaling as therapeutic target","volume":"9","author":"Dufva","year":"2018","journal-title":"Nat Commun"},{"key":"10.1053\/j.semdp.2019.12.004_bib0081","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/cr.2017.146","article-title":"Integrated genomic analysis identifies deregulated JAK\/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia","volume":"28","author":"Huang","year":"2018","journal-title":"Cell Res."},{"key":"10.1053\/j.semdp.2019.12.004_bib0082","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13000-017-0636-1","article-title":"Aggressive natural killer cell leukemia or extranodal NK\/T cell lymphoma? a case with nasal involvement","volume":"12","author":"Jin","year":"2017","journal-title":"Diagn Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0083","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood-2016-08-692590","article-title":"LGL leukemia: from pathogenesis to treatment","volume":"129","author":"Lamy","year":"2017","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.004_bib0084","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s12185-016-2068-1","article-title":"Clinical features and treatment outcome of Epstein-Barr virus-positive nodal T-cell lymphoma","volume":"104","author":"Jung","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0085","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2559.2012.04199.x","article-title":"Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral t cell lymphoma (PTCL): a clinicopathological study of 26 cases","volume":"61","author":"Kato","year":"2012","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2019.12.004_bib0086","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.humpath.2015.03.002","article-title":"Epstein-Barr virus-positive nodal T\/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features","volume":"46","author":"Jeon","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0087","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.pas.0000173238.17331.6b","article-title":"Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified","volume":"29","author":"Asano","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0088","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/his.12251","article-title":"Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European association for haematopathology and the society for hematopathology","volume":"64","author":"Attygalle","year":"2014","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2019.12.004_bib0089","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/PAS.0000000000000323","article-title":"T-cell receptor (TCR) phenotype of nodal Epstein-Barr virus (EBV)-positive cytotoxic T-cell lymphoma (CTL): a clinicopathologic study of 39 cases","volume":"39","author":"Kato","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0090","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3324\/haematol.2017.180430","article-title":"Epstein-Barr virus-associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes","volume":"103","author":"Ng","year":"2018","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2019.12.004_bib0091","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/10428194.2015.1064530","article-title":"Genetics of anaplastic large cell lymphoma","volume":"57","author":"Zeng","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2019.12.004_bib0092","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1182\/blood.V82.11.3259.3259","article-title":"Fatal Epstein-Barr virus-associated hemophagocytic syndrome","volume":"82","author":"Kikuta","year":"1993","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.004_bib0093","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood.V98.2.280","article-title":"Clinical and virologic characteristics of chronic active Epstein-Barr virus infection","volume":"98","author":"Kimura","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.004_bib0094","first-page":"1219","article-title":"Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan","volume":"144","author":"Su","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0095","first-page":"1165","article-title":"Clinicopathological states of Epstein-Barr virus-associated T\/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults","volume":"24","author":"Suzuki","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0096","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood.V96.2.443","article-title":"Fulminant EBV(+) T-cell lymphoproliferative disorder following acute\/chronic EBV infection: a distinct clinicopathologic syndrome","volume":"96","author":"Quintanilla-Martinez","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.004_bib0097","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/jcp.23.9.765","article-title":"Fatal infectious mononucleosis: a critical review","volume":"23","author":"Penman","year":"1970","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0098","doi-asserted-by":"crossref","DOI":"10.1086\/379126","article-title":"Fatal hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection in a patient with a novel mutation in the signaling lymphocytic activation molecule-associated protein","volume":"37","author":"Halasa","year":"2003","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"10.1053\/j.semdp.2019.12.004_bib0099","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ajh.10094","article-title":"Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease\/lymphoma: clinicopathologic, serologic, and molecular analysis","volume":"70","author":"Mitarnun","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000074232","article-title":"Fatal hemophagocytic lymphohistiocytosis with clonal and granular T cell proliferation in an infant","volume":"110","author":"Imashuku","year":"2003","journal-title":"Acta Haematol."},{"key":"10.1053\/j.semdp.2019.12.004_bib0101","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1053\/j.semdp.2019.12.004_bib0102","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.004_bib0103","first-page":"5738","article-title":"The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder","volume":"7","author":"Smith","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0104","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1182\/blood.V91.6.2085","article-title":"A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma","volume":"91","author":"Kanegane","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.004_bib0105","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM198803243181203","article-title":"T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections","volume":"318","author":"Jones","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2019.12.004_bib0106","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s15010-012-0321-y","article-title":"An unusual presentation of a common infection","volume":"41","author":"Richter","year":"2013","journal-title":"Infection"},{"key":"10.1053\/j.semdp.2019.12.004_bib0107","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMcp1001116","article-title":"Infectious mononucleosis","volume":"362","author":"Luzuriaga","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2019.12.004_bib0108","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3389\/fimmu.2017.01867","article-title":"Chronic active Epstein-Barr virus disease","volume":"8","author":"Kimura","year":"2017","journal-title":"Front Immunol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0109","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3324\/haematol.2017.174177","article-title":"A distinct subtype of Epstein-Barr virus-positive T\/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features","volume":"103","author":"Kawamoto","year":"2018","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2019.12.004_bib0110","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1086\/367988","article-title":"Prognostic factors for chronic active Epstein-Barr virus infection","volume":"187","author":"Kimura","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1053\/j.semdp.2019.12.004_bib0111","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/CMR.4.1.129","article-title":"Severe chronic active Epstein-Barr virus infection syndrome","volume":"4","author":"Okano","year":"1991","journal-title":"Clin Microbiol Rev"},{"key":"10.1053\/j.semdp.2019.12.004_bib0112","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/333455a0","article-title":"Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease","volume":"333","author":"Kikuta","year":"1988","journal-title":"Nature"},{"key":"10.1053\/j.semdp.2019.12.004_bib0113","doi-asserted-by":"crossref","first-page":"636","DOI":"10.7326\/0003-4819-104-5-636","article-title":"Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy","volume":"104","author":"Schooley","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semdp.2019.12.004_bib0114","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","article-title":"Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States","volume":"117","author":"Cohen","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.004_bib0115","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.004_bib0116","article-title":"Defective Epstein-Barr virus in chronic active infection and haematological malignancy","author":"Okuno","year":"2019","journal-title":"Nature microbiology"},{"key":"10.1053\/j.semdp.2019.12.004_bib0117","first-page":"280","article-title":"[The study of gene mutations in unknown refractory viral infection and primary hemophagocytic lymphohistiocytosis]","volume":"50","author":"Tong","year":"2011","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1053\/j.semdp.2019.12.004_bib0118","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1182\/blood-2003-06-2171","article-title":"Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation","volume":"103","author":"Katano","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.004_bib0119","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1365-2230.2001.00805.x","article-title":"Epstein\u2013Barr virus-associated peripheral T-cell lymphoma in adults with hydroa vacciniforme-like lesions","volume":"26","author":"Cho","year":"2001","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1053\/j.semdp.2019.12.004_bib0120","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2133.2004.06038.x","article-title":"Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases","volume":"151","author":"Cho","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0121","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archderm.142.5.587","article-title":"Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders","volume":"142","author":"Iwatsuki","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0122","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0190-9622(00)90127-0","article-title":"Hydroa vacciniforme: a clinical and follow-up study of 17 cases","volume":"42","author":"Gupta","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0123","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1136\/bjo.2004.043125","article-title":"Ocular findings as a presenting sign of hydroa vacciniforme","volume":"88","author":"Jeng","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0124","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/j.semdp.2016.11.003","article-title":"Cutaneous EBV-related lymphoproliferative disorders","volume":"34","author":"Gru","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0147","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1182\/blood.2019001031","article-title":"Deciphering hydroa vacciniforme","volume":"133","author":"Quintanilla-Martinez","year":"2019","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.004_bib0148","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood.2018893750","article-title":"Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whites","volume":"133","author":"Cohen","year":"2019","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.004_bib0125","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/PAS.0b013e3181fbb4fd","article-title":"EBV-associated cutaneous NK\/T-cell lymphoma: review of a series of 14 cases from peru in children and young adults","volume":"34","author":"Rodriguez-Pinilla","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0126","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood-2013-05-502203","article-title":"Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma","volume":"122","author":"Quintanilla-Martinez","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2019.12.004_bib0127","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/DAD.0000000000001229","article-title":"Comparative study of the clinical pathology, immunophenotype, epstein-barr virus infection status, and gene rearrangements in adult and child patients with hydroa vacciniforme-like lymphoproliferative disorder","volume":"41","author":"Wen","year":"2019","journal-title":"Am J Dermatopathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0128","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0190-9622(98)70120-3","article-title":"Angiocentric cutaneous T-cell lymphoma of childhood (hydroa-like lymphoma): a distinctive type of cutaneous T-cell lymphoma","volume":"38","author":"Magana","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0129","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1046\/j.1365-2141.2003.04359.x","article-title":"Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T\/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions","volume":"121","author":"Zhang","year":"2003","journal-title":"Brit J Haematol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0130","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000000295","article-title":"Cytotoxic T-cell and NK-cell lymphomas: current questions and controversies","volume":"38","author":"Swerdlow","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0131","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.0303-6987.2006.00548.x","article-title":"CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators","volume":"33","author":"Kempf","year":"2006","journal-title":"J. Cutan. Pathol."},{"key":"10.1053\/j.semdp.2019.12.004_bib0132","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1349-7006.1997.tb00305.x","article-title":"Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells","volume":"88","author":"Ishihara","year":"1997","journal-title":"Japanese journal of cancer research: Gann"},{"key":"10.1053\/j.semdp.2019.12.004_bib0133","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1046\/j.1365-2133.1998.02236.x","article-title":"Severe mosquito bite hypersensitivity, natural killer cell leukaemia, latent or chronic active Epstein-Barr virus infection and hydroa vacciniforme-like eruption","volume":"138","author":"Tokura","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0134","first-page":"223","article-title":"Hypersensitivity to mosquito bites is not an allergic disease, but an Epstein-Barr virus-associated lymphoproliferative disease","volume":"72","author":"Ishihara","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0135","first-page":"303","article-title":"Hypersensitivity to mosquito bite and malignant histocytosis","volume":"52","author":"Hidano","year":"1982","journal-title":"Jpn. J. Exp. Med."},{"key":"10.1053\/j.semdp.2019.12.004_bib0136","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/archderm.1990.01670270094016","article-title":"Severe hypersensitivity to mosquito bites associated with natural killer cell lymphocytosis","volume":"126","author":"Tokura","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0137","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jmii.2014.01.008","article-title":"Hypersensitivity to mosquito bites as the primary clinical manifestation of an Epstein-Barr virus infection","volume":"49","author":"Chiu","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1053\/j.semdp.2019.12.004_bib0138","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3904\/kjim.2003.18.1.50","article-title":"Hypersensitivity to mosquito bites associated with natural killer cell-derived large granular lymphocyte lymphocytosis: a case report in Korea","volume":"18","author":"Chung","year":"2003","journal-title":"Korean J. Intern. Med."},{"key":"10.1053\/j.semdp.2019.12.004_bib0139","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.0022-202X.2005.23915.x","article-title":"Mosquito salivary gland extracts induce EBV-Infected NK cell oncogenesis via CD4+ T cells in patients with hypersensitivity to mosquito bites","volume":"125","author":"Asada","year":"2005","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1053\/j.semdp.2019.12.004_bib0140","doi-asserted-by":"crossref","first-page":"e76711","DOI":"10.1371\/journal.pone.0076711","article-title":"Immunologic difference between hypersensitivity to mosquito bite and hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1053\/j.semdp.2019.12.004_bib0141","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/cas.12696","article-title":"Basophil activation by mosquito extracts in patients with hypersensitivity to mosquito bites","volume":"106","author":"Sakakibara","year":"2015","journal-title":"Cancer Sci"},{"key":"10.1053\/j.semdp.2019.12.004_bib0142","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1067\/mjd.2001.114751","article-title":"Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia\/lymphoma","volume":"45","author":"Tokura","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0b013e3182648596","article-title":"Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas","volume":"37","author":"Kempf","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2019.12.004_bib0144","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdermsci.2006.11.002","article-title":"Hypersensitivity to mosquito bites: a unique pathogenic mechanism linking Epstein-Barr virus infection, allergy and oncogenesis","volume":"45","author":"Asada","year":"2007","journal-title":"J Dermatol Sci"},{"key":"10.1053\/j.semdp.2019.12.004_bib0145","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2133.2005.06684.x","article-title":"Nodal marginal zone lymphoma in association with hydroa vacciniforme-like papulovesicular eruption, hypersensitivity to mosquito bites and insect bite-like reaction","volume":"153","author":"Yoon","year":"2005","journal-title":"Br J Dermatol"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257019301121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257019301121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:21:13Z","timestamp":1760037673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257019301121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":148,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0740257019301121"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2019.12.004","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2019.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}